Healing of a resistant neurotrophic corneal ulcer using a new matrix therapy agent (RGTA): A case report

Purpose We report a case of a resistant neurotrophic corneal ulcer successfully treated by the matrix regenerating agent (RGTA) Cacicol(®). Methods We report a case of an 18‐year‐old female patient, who developed a persistent epithelial ulcer after cataract surgery complicated by endophthalmitis, with no improvement despite 4 weeks of artificial tears. A new ophthalmologic solution based on a regenerating agent (RGTA, Cacicol20®) was then used, with a dosage of two eye drops per week for 8 weeks. Results Improvement was observed in 2 weeks, and complete healing was obtained in